258 related articles for article (PubMed ID: 1304340)
1. Direct observation by X-ray analysis of the tetrahedral "intermediate" of aspartic proteinases.
Veerapandian B; Cooper JB; Sali A; Blundell TL; Rosati RL; Dominy BW; Damon DB; Hoover DJ
Protein Sci; 1992 Mar; 1(3):322-8. PubMed ID: 1304340
[TBL] [Abstract][Full Text] [Related]
2. X-ray analyses of aspartic proteinases. III Three-dimensional structure of endothiapepsin complexed with a transition-state isostere inhibitor of renin at 1.6 A resolution.
Veerapandian B; Cooper JB; Sali A; Blundell TL
J Mol Biol; 1990 Dec; 216(4):1017-29. PubMed ID: 2266553
[TBL] [Abstract][Full Text] [Related]
3. A theoretical study of torsional flexibility in the active site of aspartic proteinases: implications for catalysis.
Beveridge A
Proteins; 1996 Mar; 24(3):322-34. PubMed ID: 8778779
[TBL] [Abstract][Full Text] [Related]
4. Structures of complexes of rhizopuspepsin with pepstatin and other statine-containing inhibitors.
Suguna K; Padlan EA; Bott R; Boger J; Parris KD; Davies DR
Proteins; 1992 Jul; 13(3):195-205. PubMed ID: 1603809
[TBL] [Abstract][Full Text] [Related]
5. X-ray structures of five renin inhibitors bound to saccharopepsin: exploration of active-site specificity.
Cronin NB; Badasso MO; J Tickle I; Dreyer T; Hoover DJ; Rosati RL; Humblet CC; Lunney EA; Cooper JB
J Mol Biol; 2000 Nov; 303(5):745-60. PubMed ID: 11061973
[TBL] [Abstract][Full Text] [Related]
6. High resolution X-ray analyses of renin inhibitor-aspartic proteinase complexes.
Foundling SI; Cooper J; Watson FE; Cleasby A; Pearl LH; Sibanda BL; Hemmings A; Wood SP; Blundell TL; Valler MJ
Nature; 1987 May 28-Jun 3; 327(6120):349-52. PubMed ID: 3295561
[TBL] [Abstract][Full Text] [Related]
7. X-ray structure of HIV-1 protease in situ product complex.
Bihani S; Das A; Prashar V; Ferrer JL; Hosur MV
Proteins; 2009 Feb; 74(3):594-602. PubMed ID: 18704947
[TBL] [Abstract][Full Text] [Related]
8. X-ray analysis of a difluorostatone renin inhibitor bound as the tetrahedral hydrate to the aspartic protease endothiapepsin.
Hoover DJ; Veerapandian B; Cooper JB; Damon DB; Dominy BW; Rosati RL; Blundell TL
Adv Exp Med Biol; 1991; 306():269-73. PubMed ID: 1812716
[No Abstract] [Full Text] [Related]
9. Three-dimensional structures of HIV-1 and SIV protease product complexes.
Rose RB; Craik CS; Douglas NL; Stroud RM
Biochemistry; 1996 Oct; 35(39):12933-44. PubMed ID: 8841139
[TBL] [Abstract][Full Text] [Related]
10. Crystallographic analysis of transition state mimics bound to penicillopepsin: difluorostatine- and difluorostatone-containing peptides.
James MN; Sielecki AR; Hayakawa K; Gelb MH
Biochemistry; 1992 Apr; 31(15):3872-86. PubMed ID: 1567842
[TBL] [Abstract][Full Text] [Related]
11. The three-dimensional structure at 2.4 A resolution of glycosylated proteinase A from the lysosome-like vacuole of Saccharomyces cerevisiae.
Aguilar CF; Cronin NB; Badasso M; Dreyer T; Newman MP; Cooper JB; Hoover DJ; Wood SP; Johnson MS; Blundell TL
J Mol Biol; 1997 Apr; 267(4):899-915. PubMed ID: 9135120
[TBL] [Abstract][Full Text] [Related]
12. X-ray analyses of aspartic proteinases. V. Structure and refinement at 2.0 A resolution of the aspartic proteinase from Mucor pusillus.
Newman M; Watson F; Roychowdhury P; Jones H; Badasso M; Cleasby A; Wood SP; Tickle IJ; Blundell TL
J Mol Biol; 1993 Mar; 230(1):260-83. PubMed ID: 8450540
[TBL] [Abstract][Full Text] [Related]
13. A structural comparison of 21 inhibitor complexes of the aspartic proteinase from Endothia parasitica.
Bailey D; Cooper JB
Protein Sci; 1994 Nov; 3(11):2129-43. PubMed ID: 7703859
[TBL] [Abstract][Full Text] [Related]
14. Crystal structures of the inactive D30N mutant of feline immunodeficiency virus protease complexed with a substrate and an inhibitor.
Laco GS; Schalk-Hihi C; Lubkowski J; Morris G; Zdanov A; Olson A; Elder JH; Wlodawer A; Gustchina A
Biochemistry; 1997 Sep; 36(35):10696-708. PubMed ID: 9271500
[TBL] [Abstract][Full Text] [Related]
15. X-ray-crystallographic studies of complexes of pepstatin A and a statine-containing human renin inhibitor with endothiapepsin.
Bailey D; Cooper JB; Veerapandian B; Blundell TL; Atrash B; Jones DM; Szelke M
Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):363-71. PubMed ID: 8424781
[TBL] [Abstract][Full Text] [Related]
16. Domain flexibility in aspartic proteinases.
Sali A; Veerapandian B; Cooper JB; Moss DS; Hofmann T; Blundell TL
Proteins; 1992 Feb; 12(2):158-70. PubMed ID: 1603805
[TBL] [Abstract][Full Text] [Related]
17. Inhibition and catalytic mechanism of HIV-1 aspartic protease.
Silva AM; Cachau RE; Sham HL; Erickson JW
J Mol Biol; 1996 Jan; 255(2):321-46. PubMed ID: 8551523
[TBL] [Abstract][Full Text] [Related]
18. Atomic resolution analysis of the catalytic site of an aspartic proteinase and an unexpected mode of binding by short peptides.
Erskine PT; Coates L; Mall S; Gill RS; Wood SP; Myles DA; Cooper JB
Protein Sci; 2003 Aug; 12(8):1741-9. PubMed ID: 12876323
[TBL] [Abstract][Full Text] [Related]
19. X-ray snapshot of HIV-1 protease in action: observation of tetrahedral intermediate and short ionic hydrogen bond SIHB with catalytic aspartate.
Das A; Mahale S; Prashar V; Bihani S; Ferrer JL; Hosur MV
J Am Chem Soc; 2010 May; 132(18):6366-73. PubMed ID: 20397633
[TBL] [Abstract][Full Text] [Related]
20. The catalytic mechanism of aspartic proteinases.
Pearl LH
FEBS Lett; 1987 Apr; 214(1):8-12. PubMed ID: 3552727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
